<http://webisa.webdatacommons.org/prov/7565517>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/452971253> .
<http://webisa.webdatacommons.org/452971253>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/452971253>	<http://www.w3.org/ns/prov#value>	"The second company, which would keep the Abbott name, will sell heart stents, infant formulas, generic drugs and other products expected to bring in $22 billion this year." .
<http://webisa.webdatacommons.org/prov/346600772>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/452971253> .
<http://webisa.webdatacommons.org/452971253>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<newsmax.com> .